Navigation Links
Endo Reports First Quarter Financial Results
Date:5/7/2013

uisition-related and integration items, net

1,318(1,318)(6)—OPERATING INCOME

$

73,992$

144,874$

218,866INTEREST EXPENSE, NET

44,303(5,450)(7)38,853NET LOSS ON EXTINGUISHMENT OF DEBT

11,312(11,312)(8)—OTHER (INCOME) EXPENSE, NET

(18,168)19,227(9)1,059INCOME BEFORE INCOME TAX

$

36,545$

142,409$

178,954INCOME TAX

9,94234,520(10)44,462CONSOLIDATED NET INCOME

$

26,603$

107,889$

134,492Less: Net income attributable to noncontrolling interests

11,254—11,254NET INCOME ATTRIBUTABLE TO ENDO HEALTH SOLUTIONS INC.

$

15,349$

107,889$

123,238DILUTED EARNINGS PER SHARE

$

0.14$

1.09DILUTED WEIGHTED AVERAGE SHARES

113,189113,189 

Notes to reconciliation of our GAAP statements of operations to our adjusted statements of operations:(1)

To exclude amortization of commercial intangible assets related to marketed products of $46,189 and certain separation benefits and other costs incurred in connection with continued efforts to enhance the company's operations.(2)

To exclude certain separation benefits and other costs incurred in connection with continued efforts to enhance the company's operations, amortization of customer relationships and mesh litigation-related defense costs.(3)

To exclude milestone payments to partners and certain separation benefits and other costs incurred in connection with continued efforts to enhance the company's operations.(4)

To exclude the net impact of accruals primarily for mesh-related product liability.(5)

To exclude asset impairment charges.(6)

To exclude acquisition-related and integration costs and a small loss recorded to reflect the change in fair value of the contingent consideration associated with the Qualitest acquisition.(7)


'/>"/>
SOURCE Endo Health Solutions
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
2. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
3. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
4. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
5. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
6. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
7. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
8. Luminex Corporation Reports First Quarter 2012 Results
9. Hospira Reports First-Quarter 2012 Results
10. Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel
11. The Female Health Company Reports Second Quarter Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... -- , The new Dompé ... information concerning the biopharmaceutical Group,s national and international clinical research ... the recently launched institutional website that is receiving accolades from ... a new chapter in the fascinating story of Drug Discovery ... panoramic hub on the world of clinical research, ranging from ...
(Date:12/17/2014)... N.J. , Dec. 17, 2014  IGI Laboratories, ... today the closing of its offering of $125 million ... 2019 (the "Notes").  The Notes were offered and sold ... under the Securities Act of 1933, as amended (the ... a fixed rate of 3.75% per year, payable semiannually ...
(Date:12/17/2014)... and RALEIGH, N.C. ... Marketing Communications, LLC (CTMC), and Integrated Clinical Trial ... recruitment and retention for clinical trials announce that ... Clinical Trial Marketing Services (i-CTMS). i-CTMS will provide ... services to pharmaceutical, biotechnology and medical device companies. ...
Breaking Medicine Technology:Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3
... HAIKOU, China , April 22 /PRNewswire-Asia-FirstCall/ ... (OTC Bulletin Board: KURU), a,leading bio-pharmaceutical company in ... peptide-based drugs and small molecule drugs, today,announced the signing ... of preferred stock and warrants with Caduceus Asia ...
... CardioGenics Inc. (OTC Bulletin Board: CGNH), a developer of technology and ... spotlighted in three publications during the month of April: Today,s Medical ... Transcript . , , ... the April 2010 print and online editions of Today,s ...
Cached Medicine Technology:Kun Run Biotechnology, Inc. Executes Purchase Agreements for Approximately $8 Million Private Placement 2Kun Run Biotechnology, Inc. Executes Purchase Agreements for Approximately $8 Million Private Placement 3Kun Run Biotechnology, Inc. Executes Purchase Agreements for Approximately $8 Million Private Placement 4CardioGenics to be Spotlighted in Three Publications During Month of April 2CardioGenics to be Spotlighted in Three Publications During Month of April 3CardioGenics to be Spotlighted in Three Publications During Month of April 4
(Date:12/19/2014)... December 20, 2014 The Medspa at ... injectable filler from respected cosmetic brand Juvéderm. Voluma XC ... with age. The Medspa at Hendrick is pleased to ... skin care technology to its clients. , Voluma is ... be FDA-approved to treat the mid-face and cheek area. ...
(Date:12/19/2014)... News) -- New research warns parents that buying an older car ... Nearly half of teen drivers killed in the United States between ... years old and often lacked important safety features that are available ... drivers killed in crashes were in cars at least six years ... 31 percent were in cars 11 to 15 years old, and ...
(Date:12/19/2014)... 2014 (HealthDay News) -- All children should have their ... preferably every year, eye experts say. The new ... panel of the U.S. National Center for Children,s Vision ... age group require screening for eye problems, particularly vision ... amblyopia ("lazy eye") and strabismus (a disorder of eye ...
(Date:12/19/2014)... FRIDAY, Dec. 19, 2014 (HealthDay News) -- Injectable drug ... double the suicide attempt rate of other substance users, ... use is associated with the risk of suicide attempt ... the University of Montreal, said in a university news ... users. We wanted to know who among substance users ...
(Date:12/19/2014)... Dec. 19, 2014 (HealthDay News) -- The cost of ... well-being, a new study finds. Researchers examined data ... been diagnosed with colorectal or lung cancer. Of those ... cancer-free, and more than 100 had advanced cancer. ... to pay their medical bills, which was linked with ...
Breaking Medicine News(10 mins):Health News:Breakthrough New Injectable Dermal Filler Voluma XC Offered by The MedSpa at Hendrick 2Health News:Older Cars a Bad Choice for Younger Drivers 2Health News:Preschoolers Need Eye Screening, Experts Say 2Health News:Cocaine, Amphetamines May Up Injection Drug Users' Suicide Risk 2Health News:Cancer Treatment Costs Weigh Heavily on Patients, Study Finds 2
... Feb. 18 As National Eating Disorders Awareness,Week approaches, ... and body image issues for millions of Americans, including ... public and healthcare professionals about males and eating,disorders is ... from,these disorders and very few professionals would even consider ...
... Safety Cautions of the Complications and Consequences of Growing and ... ... 18, 2009 -- Life-threatening kidney-failure is a strong and convincing ... a true threat to beauty and to health, cautions Physicians ...
... healthcare manufacturer introduces new product packaging and ,e-commerce feature to company ... ... Vernon, NY (PRWEB) February 18, 2009 -- The Geritrex Corporation, a ... now celebrating its 30th year in business. Founded by CEO ...
... withdrawal symptoms without side effects, early study shows , , ... used to treat nausea can prevent symptoms of withdrawal ... morphine and codeine, a new study shows. , The ... do so without some of the serious side effects ...
... conditions, report says , , WEDNESDAY, Feb. 18 (HealthDay News) -- ... the United States was born in a state that required ... by the end of 2008, all 50 states and the ... screening for at least 21 disorders, a new report finds. ...
... of Sciences will release a report, ... could improve the forensic sciences., ... United States: A Path Forward," ... forensic techniques--fingerprinting, firearms, ...
Cached Medicine News:Health News:Remuda Ranch Seeks to Increase Awareness of Eating Disorders Among Males During National Eating Disorders Awareness Week (NEDAW), February 22-28, 2009 2Health News:Inexpensive and Illegal Buttock - Boosting Injections Not Pretty 2Health News:Inexpensive and Illegal Buttock - Boosting Injections Not Pretty 3Health News:Inexpensive and Illegal Buttock - Boosting Injections Not Pretty 4Health News:Inexpensive and Illegal Buttock - Boosting Injections Not Pretty 5Health News:A "Healthy" Company - Geritrex Celebrates Its 30 Year Anniversary with New Rebranding Effort and Expanding Distribution Channels 2Health News:Nausea Drug Shows Promise Against Opioid Addiction 2Health News:Newborn Screenings Now Required Across U.S. 2Health News:Newborn Screenings Now Required Across U.S. 3Health News:NAS Releasing Forensics Report: Expert Available 2
... Allograft is processed from 100% cortical bone, ... The graft is machined with a textured ... graft migration. The intermedulary canal accommodates autograft ... Allografts contain a relief orientation in either ...
Lumbar Allograft with Osteoactive advantage. Promotes bone formation and faster incorporation. Derived from the proven technology behind Grafton DBM. Maintains structural integrity and strength....
... Anteater Titanium Microdiscectomy System offers ... spinal surgery. The boss anteater titanium ... herniated intervertebral discs provides for less ... The retractor is designed to provide ...
Meyerding Laminectomy Retractors, self-retaining....
Medicine Products: